Reporting its fourth quarter results for FY 26, Zydus Wellness, reported a consolidated growth of 62.1% in Net Sales which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year.
Cancer drug research continues to transform the global pharmaceutical industry as companies race to develop affordable and advanced oncology treatments. New FDA clearances reflect rapid growth in cancer drug research, especially in the breast...
Indoco Remedies Ltd. has announced that its manufacturing facility for solid oral dosage forms (Unit I) located at Baddi has received an EU GMP certificate from the Malta Medicines Authority, marking the company’s first step to European entry.
The Bajaj Group’s ?2,000 crore healthcare bet is officially underway in Pune, as the diversified conglomerate prepares to enter India’s healthcare sector with an ambitious long-term expansion strategy. The group plans to invest over ?2,000 crore...
Tata Group’s Arthritis Drug Deal with Vyome Holdings marks a major step in India’s growing biotech and pharmaceutical innovation space. The Arthritis Drug Deal involves Tata-backed Impetis Biosciences out-licensing two experimental drugs designed...
Biocon, Health Canada approval, and antifungal injection developments received a major boost after Biocon Pharma Ltd secured approval for Micafungin for Injection, strengthening the company’s presence in regulated international pharmaceuti...
Public Healthcare infrastructure in Delhi is set for a major expansion after the state government approved a Rs 805.99 crore medical college and hostel project in Dwarka. The upcoming facility, planned at the Indira Gandhi Hospital campus...
India’s private healthcare crisis is raising serious concerns about the future of affordable treatment for millions of patients. Several leading private hospital chains are reconsidering their participation in government-backed health schemes...
The Zydus Biologics plant has received seven observations from the US Food and Drug Administration (USFDA) after a recent inspection at the company’s injectable manufacturing facility in Ahmedabad. The inspection was carried out betwe...
Biocon Biologics has received five procedural observations from the U.S. Food and Drug Administration (USFDA) after an inspection at its Bengaluru manufacturing facility, drawing attention to the company’s regulatory compliance process...
, CDSCO.jpg)